AQR Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $281M | Buy |
|
|||||
|
2025
Q1 | $364M | Buy |
|
|||||
|
2024
Q4 | $227M | Buy |
|
|||||
|
2024
Q3 | $200M | Buy |
|
|||||
|
2024
Q2 | $111M | Buy |
|
|||||
|
2024
Q1 | $126M | Buy |
|
|||||
|
2023
Q4 | $108M | Sell |
|
|||||
|
2023
Q3 | $131M | Sell |
|
|||||
|
2023
Q2 | $186M | Buy |
|
|||||
|
2023
Q1 | $189M | Buy |
|
|||||
|
2022
Q4 | $160M | Buy |
|
|||||
|
2022
Q3 | $116M | Buy |
|
|||||
|
2022
Q2 | $120M | Buy |
|
|||||
|
2022
Q1 | $106M | Sell |
|
|||||
|
2021
Q4 | $95.1M | Sell |
|
|||||
|
2021
Q3 | $92.2M | Sell |
|
|||||
|
2021
Q2 | $134M | Sell |
|
|||||
|
2021
Q1 | $173M | Sell |
|
|||||
|
2020
Q4 | $173M | Sell |
|
|||||
|
2020
Q3 | $193M | Sell |
|
|||||
|
2020
Q2 | $196M | Sell |
|
|||||
|
2020
Q1 | $223M | Buy |
|
|||||
|
2019
Q4 | $234M | Buy |
|
|||||
|
2019
Q3 | $154M | Sell |
|
|||||
|
2019
Q2 | $347M | Sell |
|
|||||
|
2019
Q1 | $400M | Sell |
|
|||||
|
2018
Q4 | $443M | Buy |
|
|||||
|
2018
Q3 | $386M | Buy |
|
|||||
|
2018
Q2 | $288M | Buy |
|
|||||
|
2018
Q1 | $211M | Sell |
|
|||||
|
2017
Q4 | $250M | Buy |
|
|||||
|
2017
Q3 | $197M | Buy |
|
|||||
|
2017
Q2 | $125M | Buy |
|
|||||
|
2017
Q1 | $26M | Buy |
|
|||||
|
2016
Q4 | $23.9M | Sell |
|
|||||
|
2016
Q3 | $43.9M | Buy |
|
|||||
|
2016
Q2 | $45.1M | Sell |
|
|||||
|
2016
Q1 | $52.3M | Sell |
|
|||||
|
2015
Q4 | $82.2M | Sell |
|
|||||
|
2015
Q3 | $116M | Buy |
|
|||||
|
2015
Q2 | $90.7M | Buy |
|
|||||
|
2015
Q1 | $30.6M | Buy |
|
|||||
|
2014
Q4 | $24.9M | Sell |
|
|||||
|
2014
Q3 | $58.1M | Buy |
|
|||||
|
2014
Q2 | $48.4M | Buy |
|
|||||
|
2014
Q1 | $29.8M | Buy |
|
|||||
|
2013
Q4 | $25.7M | Buy |
|
|||||
|
2013
Q3 | $15.3M | Buy |
|
|||||
|
2013
Q2 | $14.7M | Buy |
|